The addition of RARP to ADT significantly increased the rate of achieving radical level PSA levels (74.7% vs 38.3%; P <.001) and a shorter time to PSA nadir (2 vs 6 months; P <.001) compared with ADT ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

Metastasis-directed therapy added to ADT helps slow the progression of metastatic prostate cancer, a phase 2 trial finds. The addition of metastasis-directed therapy (MDT) to androgen deprivation ...

SAN FRANCISCO -- Men with high-risk localized prostate cancer lived significantly longer with dose-escalated radiation therapy (RT) plus long-term androgen deprivation therapy (ADT), according to long ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Prostate cancer treatment, particularly hormone therapy, significantly disrupts sleep, leading to fatigue and reduced daytime ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...